Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01234077 · ClinicalTrials.gov registry record · NA

Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device

A NA study of Sleep Disorder, sponsored by National Jewish Health.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01234077 is a NA study of Sleep Disorder that has completed, run by National Jewish Health. The registered enrollment target is 50 participants, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01234077, a NA study of Sleep Disorder, has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting. The purposes of this study are to: a) determine if the ECG data collected using the CPC M1 device is at least as good as the ECG data collected during a diagnostic, in-lab polysomnogram (PSG) (or sleep study) and b) determine if in-home monitoring with the device will provide similar results compared to an in-lab PSG.

Conditions Studied

Interventions

  • DEVICE CPC M1

Study Locations (1)

Colorado

  • National Jewish Health - Denver

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2010-03
Est. Completion 2010-09
Phase NA

Sponsor

National Jewish Health

83 total trials

What the Registry Record Tells You About NCT01234077

The ClinicalTrials.gov registry entry for NCT01234077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 1 intervention - of which CPC M1 is the first listed.

NCT01234077 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01234077 about?

NCT01234077 is a clinical study titled "Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device". Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting. The purposes of this study are to: a) determi...

What is the current status of trial NCT01234077?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-03. Estimated completion is 2010-09.

What conditions does trial NCT01234077 study?

This clinical trial studies the following conditions: Sleep Disorder.

What interventions are being tested in trial NCT01234077?

The interventions under investigation include: CPC M1 (DEVICE).

Who is sponsoring clinical trial NCT01234077?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01234077 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.